The Expression of p16 and Cyclin D1 in Proliferative Endometrium and Endometrial Carcinoma
Zhu Gai
Abstract
Zhu Gai
Abstract
Objectives:To study the role of p16 and cyclinD1 in the genesis and development of endometrial carcinoma.Methods:12 cases of normal endometrium,22 cases of proliferative endometrium and 41 cases of endometrial carcinoma were detected for the expression of p16 and cyclinD1 by means of immuniohistochemical S-P. Results:Among the groups of the simple and compound hyperplasia,the atypical hyperplasia and the endometrial carcinoma,p16 showed a descending tendency ,while the expression of cyclinD1 showed an ascending tendency.In endometrial carcinomas,the expression of p16 was significantly lower than normal endometrium and proliferative endometrium( P 0.01, P 0.05).However,the expression of cyclinD1 in proliferate endometrium and endometrial carcinoma was significantly higher than that in normal endometrium( P 0.05, P 0.01).The overexpression of cyclinD1 in the atypical hyperplasia group was obviously different from that in the simple and compound hyperplasia proup( P 0.01).In endometrial carcinoma,the expression of p16 was decreasing with the descending of cell differentiate degree,on the opposite,the expression of cyclinD1 was increasing,which indicated a negative correlation between them.Conclusions:The aberrant expression of p16 cyclinD1 was involved in the genesis of endometrial carcinoma;The low expression of p16 and the over expression of cyclinD1 correlate with the malicious biological behaviors of endometrial carcinoma;Over expression of cyclinD1 may be an earlier molecular event.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objectives:To study the role of p16 and cyclinD1 in the genesis and development of endometrial carcinoma.Methods:12 cases of normal endometrium,22 cases of proliferative endometrium and 41 cases of endometrial carcinoma were detected for the expression of p16 and cyclinD1 by means of immuniohistochemical S-P. Results:Among the groups of the simple and compound hyperplasia,the atypical hyperplasia and the endometrial carcinoma,p16 showed a descending tendency ,while the expression of cyclinD1 showed an ascending tendency.In endometrial carcinomas,the expression of p16 was significantly lower than normal endometrium and proliferative endometrium( P 0.01, P 0.05).However,the expression of cyclinD1 in proliferate endometrium and endometrial carcinoma was significantly higher than that in normal endometrium( P 0.05, P 0.01).The overexpression of cyclinD1 in the atypical hyperplasia group was obviously different from that in the simple and compound hyperplasia proup( P 0.01).In endometrial carcinoma,the expression of p16 was decreasing with the descending of cell differentiate degree,on the opposite,the expression of cyclinD1 was increasing,which indicated a negative correlation between them.Conclusions:The aberrant expression of p16 cyclinD1 was involved in the genesis of endometrial carcinoma;The low expression of p16 and the over expression of cyclinD1 correlate with the malicious biological behaviors of endometrial carcinoma;Over expression of cyclinD1 may be an earlier molecular event.
Key concepts: Endometrium, Carcinoma, Atypical hyperplasia, Endometrial hyperplasia, Medicine, Hyperplasia, Cyclin D1, Cancer research